Citadel Advisors
BHST

Citadel Advisors’s BioHarvest Sciences BHST Stock Holding History

Citadel Advisors’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2K Buy
20,652
+5,899
+40% +$22.5K ﹤0.01% 13053
2026
Q1 		$64K Sell
14,753
-614
-4% -$2.89K ﹤0.01% 12297
2025
Q4 		$79.8K Buy
+15,367
New +$123K ﹤0.01% 11798

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors's BHST Position: Q2 2026 in Review

Citadel Advisors increased its BioHarvest Sciences (BHST) stake by 40% in Q2 2026, buying an estimated $22.5K and bringing the position to 20,652 shares worth $58.2K. The position accounts for ﹤0.01% of the portfolio, ranked #13053.

Citadel Advisors first reported a position in BHST in Q4 2025 and has held it in 3 quarters since. The position peaked at $79.8K in Q4 2025. 19 funds tracked by Wall St. Rank hold BHST as of Q2 2026.

  • Citadel Advisors held 20,652 shares of BioHarvest Sciences worth $58.2K as of Q2 2026.
  • Citadel Advisors bought 5,899 BioHarvest Sciences shares in Q2 2026, an estimated $22.5K.
  • BioHarvest Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13053 holding.
  • Citadel Advisors first reported a position in BioHarvest Sciences in Q4 2025 and has held it in 3 quarters since.
  • Citadel Advisors's BioHarvest Sciences position peaked at $79.8K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.